Aaron Judge’s massive postseason performance made it easy to forget he’s been dealing with a flexor strain in his right elbow since July. The slugger had multiple hits in all but one game across the first two rounds of the playoffs. Judge engineered a defining postseason moment in Game 3 against Toronto, smashing a game-tying homer off Louis Varland.
With the Yankees now headed into the offseason, Judge was asked about the plan for his ailing elbow. “We’ll definitely do some work on it and get it right,” Judge told reporters, including Chris Kirschner of The Athletic. When asked about surgery specifically, Judge remained noncommittal. “I’m not a doctor. I don’t know.”
The flexor strain forced Judge to the IL in late July. It was a minimum stint on the IL, but he was unable to play the field upon returning. Judge spent all of August at DH. He made it back to his familiar home in right field on September 5. Judge bounced between right field and DH for the final month of the season. In the playoffs, he played exclusively in the field, with Giancarlo Stanton manning the DH spot in all seven games.
Initial tests did not reveal any ulnar collateral ligament damage for Judge. His recovery from surgery to address the flexor strain, if he were to go that route, would not be as long as for a more serious elbow injury like a UCL tear.
Anthony Volpe was similarly tight-lipped about offseason surgery for his shoulder injury. “I anticipated playing another month and then reassessing then. So nothing’s [decided] … we’re going to figure it out,” Volpe told reporters, including Bryan Hoch of MLB.com.
Volpe partially tore the labrum in his shoulder back in May. He didn’t go on the IL with the injury, but his performance suffered. Volpe slashed a solid .237/.328/.456 through April. His numbers tumbled to .205/.255/.374 over the final five months of the season. Volpe got off to a strong start in the postseason, going 4-for-11 with a home run in the Wild Card round against Boston. He collapsed in the ALDS, managing just one hit in 15 at-bats. Volpe struck out 11 times in the four games against Toronto.
Depending on the severity of the tear, Volpe could elect surgery and still be ready for the 2026 season. Shohei Ohtani tore the labrum in his non-throwing shoulder during the World Series in 2024. He made it back in time for spring training this year.
While Volpe never hit the IL with the shoulder issue, he did miss time in mid-September after receiving a cortisone injection. Midseason acquisition Jose Caballero started six straight games at shortstop from September 10-15. Caballero receded to a bench role once Volpe was deemed healthy, but he did endear himself to Yankees fans with a walk-off single to clinch a postseason bid in the final week of the season. Caballero is under team control through 2029 and could factor into New York’s middle infield plans depending on the health of Volpe.
No matter what Judge and Volpe decide on the surgery front, they’ll definitely be back with the team next season. The same can’t be said for Cody Bellinger, who is facing a decision of his own. Bellinger can opt out of the final year of his current contract with the Yankees. He’d be leaving $25MM on the table in pursuit of a longer, potentially more lucrative deal in free agency.
Hoch passed along comments from Bellinger about the pending opt-out decision. As has been the theme with these Yankees, Bellinger didn’t say much. “Obviously, things to discuss with family and the agent and the business side of it all. But tonight, I’m just going to soak it all in and just be a part of the group one more time.”
Bellinger signed his current three-year, $80MM contract with the Cubs ahead of the 2024 season. He could’ve opted out of the deal this past offseason, but declined. Bellinger was then dealt to the Yankees. He slugged 29 home runs in his first year in pinstripes, his most since his 2019 NL MVP season. Bellinger also stayed healthy, topping 600 plate appearances for just the third time in his career. He’s widely expected to opt out of the final year of his deal.
